Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T23:24:31.029Z Has data issue: false hasContentIssue false
  • English
  • Français

Monitoring skills – Asthma

Published online by Cambridge University Press:  22 June 2006

Trisha Weller
Trisha Weller
Affiliation:
Asthma Module Leader, National Respiratory Training Centre, Warwick, UK
Get access Rights & Permissions [Opens in a new window]

Extract

Summary

Asthma is a common respiratory disease in the UK with over 5 million sufferers. It a reversible airways disease characterised by bronchoconstriction, inflammation, oedema and mucus production. There is a wide spectrum of severity and asthma can be controlled effectively by pharmacotherapy. The British Guideline on the Management of Asthma provides the framework for treatment. Primary care nurses have been involved in the management of asthma for many years and a large number have undertaken asthma training courses. The asthma guidelines recognise the benefit of trained asthma nurses in the provision of care.

The revised General Medical Services contract rewards practices who provide asthma care under the Quality Indicators framework. Supplementary nurse prescribing allows nurses with appropriate training to prescribe asthma medication, providing the diagnosis of asthma is confirmed by a medical practitioner and a clinical management plan is used. Community pharmacists have an important role in the care of patients with asthma as well and some pharmacists have become supplementary prescribers. Their role will become more evident in the future.

The main asthma medications are bronchodilators and inhaled steroids, which should be used at the lowest dose to control symptoms. Caution should be exercised in young children where many asthma medications are used ‘off-label’. Their use can be justified when it is the most appropriate medication and is supported by evidence such as asthma guidelines.

All patients on asthma medicines should be monitored closely, not only to ensure control of symptoms but to monitor for adverse side effects. Sufficient knowledge of appropriate pharmacology is required by those involved in asthma management. Regular asthma review should be structured and include issues of adherence to medication, appropriate use, inhaler technique, current symptoms and effects on lifestyle. All patients should have an asthma action plan so they know how to manage their asthma. This action plan is agreed with the patient and the health professional. Appropriate asthma management and supplementary prescribing will enhance patient care.

Keywords

Asthmaguidelinebronchodilatorssteroidscontrolmonitoredaction planevidencereviewtraining
Type
Focus On
Information
Nurse Prescriber , Volume 1 , Issue 10 , October 2004 , pp. 1 - 7 , e189
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

National Asthma Campaign (NAC). Out in the open. Asthma J. 2001; 6 (3) (suppl), 1–14.
British Thoracic Society. The burden of lung disease. A statistics report from the British Thoracic Society; 2001. London.
British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Revised ed. Edinburgh: SIGN; 2004. (SIGN publication no. 63). [cited 20 Apr 2004]. Available from url: http://www.sign.ac.uk/guidelines/fulltext/63/index.html (accessed 29/10/2004)
DHSS. General practice in the National Health Service. A new contract. London: HMSO; 1990.
DoH. The health of the nation: a strategy for health in England. London: HMSO; 1992.
Fleming DM, Sunderland R, Cross KW, Ross AM, Declining incidence of episodes of asthma: a study of trends in new episodes presenting to general practitioners in the period 1989–98. Thorax. 2000; 55 (8): 657–661.Google Scholar
Weller T, Booker R, Walker S, Declining incidence of episodes of asthma: letter. Thorax. 2001; 56 (3): 246.Google Scholar
DoH. Investing in general practice: the New General Medical Services Contract. London: DoH; 2003
MCA. Proposals for supplementary prescribing by nurses and pharmacist and proposed amendments to the Prescription Only Medicines (Human Use) Order 1997 MLX 284; 2003.
Dickinson J, Hutton S, Atkin A, et al. Reducing asthma morbidity in the community: the effect of a targeted nurse-run asthma clinic in an English general practice. Respir Med. 1997; 91: 634–640.Google Scholar
Todd G, Dunlop K, McNaboe J, Ryan MF, Carson D, Shields MD, Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet. 1996; 348: 27–29.Google Scholar
Todd GRG, Acerini CL, Buck JJ, Murphy NP, Ross-Russell R, Warner JT, McCance DRAcute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Resp J. 2002; 19: 1207–1209.Google Scholar
Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thompson NC, Stepping down inhaled corticosteroids in asthma: a randomised controlled trial. Br Med J. 2003; 326: 1115–1118.Google Scholar
Royal College of Paediatricians and Child Health. The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice, In: Medicines for children, 2nd edn. Royal College of Paediatricians and Child Health, ed., RCPCH Publications Limited, London, 2003; xvi–xviii.
MHRA. The Yellow Card scheme: Extension of the Yellow Card Scheme to nurse reporters. 2004 (updated 29/01/04). Available from: http://medicines.mhra.gov.uk/ourwork/monitorsafequalmed/yellowcard/nurses. htm (accessed 18 July 2004)